Clinical TopicsWeb Exclusives

FDA approves Elelyso for Gaucher disease


On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

The rash from Rocky Mountain spotted fever usually begins to develop on which parts of the body?

Recent Posts